Susan Hasty, Publisher
Table of Contents . . . November 30th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Law Weekly | Other Publications
Alpharma, Inc. - Generic pharmaceutical firm reports loss of $0.09 per share
American Occupational Therapy Association - Californians lose millions in workers' compensation benefits
American Physical Therapy Association - Physical therapists applaud new Medicare rule
Amrad Corporation Limited - Cancer research deal signed for development of VEGF-B
Animas Corporation - Technology for disposable insulin micro-pumps, micro-needles acquired
Blue Shield of California - Insurer offers improved prescription drug coverage for Medicare Advantage HMO
Centocor - New reimbursement policy increases patient access to REMICADE
Columbia University - During active memory, carriers of AD gene think differently from noncarriers
Compugen, Ltd. - Drug and diagnostic discovery company provides Q3 update; revenues dip
Cyberonics, Inc. - 2005 Medicare outpatient reimbursement rates issued for VNS therapy
Drug Importation - Health minister: It's "unethical" to prescribe drugs without knowing patient
Drug Importation - Health official anticipates hold-up in Canadian pharmacy licensing
Elan Corporation - Pharma company names general counsel
Finance - Express Scripts reports third-quarter earnings
Medical Malpractice - Board clears dentist of wrongdoing in boy's death
Advancis Pharmaceutical Corporation - Researchers report on pulsatile dosing of antimicrobials at conference
Albany Molecular Research, Inc. - Drug discovery firm promotes two key technical leaders
Alfa Health Care, Greece - Vaccination against typhoid fever in travelers is not cost-effective
Alkermes, Inc. - Pharmaceutical company reports loss of $0.16 per share
American Scientific Resources, Inc. - Novation contract signed for asthma monitor
Androclus Therapeutics - Biotech company announces formation of clinical advisory board
AngioDynamics, Inc. - Device company presents new VenaCure procedure kit
Ankara University - Nanoparticle and emulsified influenza antigen vaccines developed
Antares Pharma, Inc. - Transdermal delivery gel technology compared to testosterone patch
Argenta-Discovery, Ltd. - Harry Finch named as senior VP at drug development firm
AstraZeneca - Pharmaceutical firm withdraws Symbicort file for European Union
Aventis - E.U. approves Taxotere (docetaxel) in prostate cancer
Bayer Healthcare - Avelox study reports faster symptom relief, earlier hospital discharge
Boston University - Marginal zone B cells deposit immune complexes onto dendritic cells
Bristol-Myers Squibb - Trials show hepatitis B agent a statistical improvement in infected patients
Business Update - Hill-Rom signs license agreement with Span-America Medical Systems
CHU de Grenoble - Pancreatic islet transplantation reviewed
CNRS - Comprehensive screening detects new epitopes in hepatitis C virus NS3 antigen
CSIRO Plant Industry - Sleeping poppies stripped of their opium
Cairo University - Antigen peptides from Schistosoma dehydrogenase used for vaccines
Canakkale Onsekiz Mart University - Alternative splicing efforts can be manipulated to rebalance Bcl-2 proteins
Cancer Ctr. Res. Inst., Japan - MY018B gene alterations appear to be important in carcinogenesis
Catalyst Biosciences, Inc. - Protein therapeutics company raises $10 million in series A financing
Center for Genetic Engineering & Biotechnology - Coadministered antigens may afford better protection against hepatitis B
Centers for Medicare & Medicaid Services - Medicare announces new payment system for inpatient psychiatric facilities
Chronic Illnesses - Report hails benefits of new approach to diabetes, asthma, and heart failure
City College of New York - Epstein-Barr virus antigen elicits anti-dsDNA and anti-Sm antibodies
Clinical Cell Culture, Ltd. - Lab equipment maker reports work on ReCell meets expectations
Colon Cancer Concern - Oncologists say newly diagnosed colon cancer patients could benefit from chemotherapy
Colorectal Cancer - Caffeinated coffee, but not decaf or tea, may have some protective effect
Conceptus, Inc. - New CPT code values provided for Essure procedure
Connetics Corp. - U.S. FDA approves Evoclin for treating acne
CryoCor, Inc. - CryoBlator approved for use in U.S. trials, CE marked in Europe
Curie Institute, Paris - Role of radiotherapy in treatment reviewed
DURECT Corp. - Company launches phase II clinical program for postoperative pain relief
Dendreon Corp. - Company achieves commercial scale of antigen for Provenge
Electro-Optical Sciences, Inc - Vision technology firm raises $9M, obtains protocol agreement for MelaFind
Emory University - Long-term immune memory cells do not develop during chronic viral infections
Emory University - Pravastatin has neutral interaction profile relative to cytochrome inhibitors
Endologix, Inc. - U.S. FDA gives conditional approval letter for Powerlink system
Erasmus Medical Center, Rotterdam - Patients with heart failure on coumarin should be closely monitored
FibroGen, Inc. - Data show FG-3019 improves kidney function in late-stage disease model
First Marketing - New product to shorten clinical trial stage introduced
Genzyme Corp. - Company seeks new therapeutic indication for Thyrogen
Mayo Clinic - Study finds new treatment option for moderately active ulcerative colitis
Medical Malpractice - Doctors are being encouraged to say they are sorry to avoid malpractice suits
National Inst. Biology Std. & Cntls, Hertfordshire - Inactivated vaccines for pandemic influenza reviewed
National University of Singapore - Infectious entry occurs through clathrin-mediated endocytic pathway
NitroMed, Inc. - African American heart failure trial data submitted to the U.S. FDA
Novartis - Femara gets U.S. FDA nod as post-tamoxifen treatment for early breast cancer
PRAECIS PHARMACEUTICALS INCORPORATED - Pharmaceutical company announces revenues of $1M due to Plenaxis sales
Par Pharmaceutical Companies, Inc. - Generic drug maker announces tentative approval of restosterone gel 1%
Pfizer, Inc. - Studies show single-dose azithromycin as effective as multi-dose for infections
Ranbaxy Inc. - Pharma company files application with FDA for antiretroviral agent
Royal Philips Electronics - Blood-oxygen saturation sensor receives FDA clearance
Schering-Plough Corporation - FDA grants priority review status for brain tumor drug; EMEA application made
Takeda Pharmaceuticals North America - NDA filed for combination type 2 diabetes medication and metformin HCl
Transplant Medicine - Michigan seeks medical records in failed kidney transplant case
U.S. Food & Drug Administration - Surrogate method for predicting poliovirus vaccine efficacy developed
University of California - $30M gift from The Skaggs Institute supports new pharmacy school
University of Wisconsin - Hemagglutinin of 1918 pandemic influenza A virus confers enhanced pathogenicity
VERSAR, Inc. - Biodefense Laboratory gets BSL-3 certification under CDC/NIH requirements
Varian Medical Systems, Inc. - 3D imaging allows tumor targeted scan for radiotherapy with linear accelerators
Vical Inc. - Plasmid DNA vaccine protects against aerosolized anthrax spores
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.